Abstract 1523: A Novel SCN5A Gain-of-Function Mutation M1875T Associated with Familial Atrial Fibrillation

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Takeru Makiyama ◽  
Masaharu Akao ◽  
Satoshi Shizuta ◽  
Takahiro Doi ◽  
Kei Nishiyama ◽  
...  

Background: Mutations in the cardiac sodium (Na + ) channel gene, SCN5A , have been associated with a variety of inherited arrhythmias, but the gain-of-function type modulation in SCN5A is associated with only one phenotype, long-QT syndrome type3 (LQTS3). Methods and Results: We studied a Japanese family with autosomal dominant hereditary atrial fibrillation (AF), multiple members of which showed onset of AF or frequent premature atrial contractions at a young age. The 31-year-old proband received radio-frequency catheter ablation, during which time numerous ectopic firings and increased excitability throughout the right atrium were documented. Mutational analysis identified a novel missense mutation, M1875T, in SCN5A . Further investigations revealed the aggregation of this mutation in all of the affected individuals (Figure A ). Functional assays of the M1875T Na + channels using whole-cell patch-clamp demonstrated a distinct gain-of-function type modulation; a pronounced depolarized shift (+16.4 mV) in V 1/2 of the voltage dependence of steady-state inactivation (Figure B ), and no late Na + current which is a defining mechanism of LQTS3. These biophysical features of the mutant channels are potentially associated with increased atrial excitability and normal QT interval in all of the affected individuals. Conclusions: We identified a novel SCN5A mutation associated with familial AF. The mutant channels displayed a gain-of-function type modulation of cardiac Na + channels, which is a novel mechanism predisposing increased atrial excitability and familial AF. This is a new phenotype resulting from the SCN5A gain-of-function mutations and is distinct from LQTS3.

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Julie Rutberg ◽  
Hai Huang ◽  
Robert Lemery ◽  
Anthony Tang ◽  
David Birnie ◽  
...  

Background : Few genetic etiologies are known for familial or sporadic cases of atrial fibrillation, which is the most common arrhythmia in older adults. We report a mother and son, both with atrial fibrillation, who were found to have a novel mutation in the sodium channel gene, SCN5A. Case History: The proband, a 50 year old male, first developed paroxysmal atrial fibrillation following orthopedic surgery. At age 57, he presented with increasing fatigue and shortness of breath and was found to have chronic atrial fibrillaion. Cardiac testing found no evidence of ischemia, normal left ventricular function and mild left atrial dilation. His mother had paroxysmal atrial fibrillation, diagnosed at age 63, and a history of well-controlled hypertension and palpitations. Her atrial fibrillation was initially controlled by sotalol, but worsening symptoms led to a change to amiodarone at age 83. Her echo showed mild biatrial enlargement. ECGs for the proband and his mother have never demonstrated conduction system disease, long QT, or a Brugada pattern. Methods and Results: Genomic DNA isolated from blood lymphocytes was screened using direct sequencing techniques. Genes previously reported to be associated with atrial fibrillation, KCNA5, GJA5 and KCNQ1, were screened and no mutations were found. In the sodium channel gene, SCN5A, a novel missense mutation was identified (c. 1493K>R) in both the proband and his mother, but not in an unaffected sibling or in the proband’s 2 asymptomatic offspring. The mutation is in a highly conserved lysine residue in the voltage-gated sodium channel gene family. Functional studies recorded macroscopic sodium currents from tsA201 cells expressing both the wild-type (Nav1.5/WT) and mutant channel (Nav1.5/K1493R). The mutant channel exhibited fast activation and inactivation kinetics and an increase in current density. No effect on steady-state activation and inactivation were observed, however, current deactivation was faster in mutant Nav1.5/K1493R as compared to the WT channels. Conclusions: This is the first report of an inherited SCN5A mutation in familial atrial fibrillation. Functional studies suggest a ’gain-of-function’ effect of the identified Nav1.5/K1493R mutation.


Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Dawood Darbar ◽  
Robert Abraham ◽  
Gayle Kucera ◽  
Tanya Stubblefield ◽  
Tao Yang ◽  
...  

Background : Family history is a risk factor for atrial fibrillation (AF). We report here a 3-generation Caucasian family with familial AF and a highly dysfunctional mutation in KCNQ1 . Methods and Results: In the proband, there was a 9-bp duplication resulting in insertion of the amino acids IAP (IAP54 –56) in the N-terminus of the protein. The kindred included 4 other family members with AF or palpitations. Each affected family member presented with early onset paroxysmal lone AF and no QT prolongation. This variant has previously been reported in presumed healthy African-American individuals (minor allele frequency 1.3%), but has not been studied in vitro . In transfected CHO cells, coexpression of IAP54 –56 with KCNE1 generated currents that were much larger and activated much earlier that wild-type I Ks ( Figure ); e.g. at +20 mV, peak current was 75±8 [IAP54 –56] vs 25±5 [wt] pA/pF after 5-sec pulses (n=7 each, P<0.001). Computational simulations of human atrial action potential (AP) that incorporated Markov models of wt or IAP54 –56-I Ks were performed. At a cycle length of 400ms, accelerated activation of IAP54 –56-I Ks resulted in open state accumulation and increased maximum I Ks amplitude ~40-fold (351 vs 9 pA/pF), resulting in ~6-fold AP duration shortening (44 vs 259 ms). Conclusions: We have identified a KCNQ1 indel in a moderate sized Caucasian kindred with familial AF and normal QT intervals. This variant results in an I Ks gain-of-function and the resulting shortening of atrial action potentials may predispose to AF. This variant has been reported in 1.3% of African-Americans, suggesting it may be a common risk allele in some populations.


2019 ◽  
Vol 123 (5) ◽  
pp. 787-793 ◽  
Author(s):  
Asma Mechakra ◽  
Tim Footz ◽  
Michael Walter ◽  
Amelia Aránega ◽  
Francisco Hernández-Torres ◽  
...  

2004 ◽  
Vol 75 (5) ◽  
pp. 899-905 ◽  
Author(s):  
Yiqing Yang ◽  
Min Xia ◽  
Qingfeng Jin ◽  
Saïd Bendahhou ◽  
Jingyi Shi ◽  
...  

2005 ◽  
Vol 332 (4) ◽  
pp. 1012-1019 ◽  
Author(s):  
Min Xia ◽  
Qingfeng Jin ◽  
Saïd Bendahhou ◽  
Yusong He ◽  
Marie-Madeleine Larroque ◽  
...  

2008 ◽  
Vol 52 (16) ◽  
pp. 1326-1334 ◽  
Author(s):  
Takeru Makiyama ◽  
Masaharu Akao ◽  
Satoshi Shizuta ◽  
Takahiro Doi ◽  
Kei Nishiyama ◽  
...  

2009 ◽  
Vol 87 (11) ◽  
pp. 954-962 ◽  
Author(s):  
Qiang-Ni Liu ◽  
Li Zhang ◽  
Pei-Li Gong ◽  
Xiao-Yan Yang ◽  
Fan-Dian Zeng

We have previously reported that dauricine exerted antiarrhythmic effects on various experimental arrhythmias. To further clarify its mechanism, the effects of dauricine on action potential duration (APD), early afterdepolarizations (EADs), triangulation, which is defined as the repolarization time from APD at 30% level (APD30) to APD at 90% level (APD90), and L-type calcium current (ICa-L) were studied using standard microelectrode techniques on rabbit papillary muscles and whole-cell patch clamp techniques on single myocytes isolated from rabbits by enzymatic digestion, respectively. Cardiac hypertrophy was induced by coarctating the abdominal aorta of rabbits. The results showed that in papillary muscles of hypertrophied rabbits, 1 µmol/L dofetilide, a selective IKr blocker, prolonged APD50 and APD90 and induced EADs (4/6, p < 0.01) with hypokalemia ([K+]o = 2.7 mmol/L). Dauricine inhibited EADs (p < 0.01) and shortened the prolonged APD (p < 0.01). In single myocytes, dauricine also inhibited EADs induced by dofetilide, hypokalemia, and hypomagnesaemia. Dauricine decreased the triangulation and reduced the peak amplitude of ICa-L at all potentials tested. Dauricine shifted the steady-state activation curves to the right and steady-state inactivation curves to the left and prolonged the τ value of the recovery curve. These results suggest that dauricine inhibits EADs and this effect may be associated with its blockade of ICa-L.


Sign in / Sign up

Export Citation Format

Share Document